SCHEMBL760499

SCHEMBL760499

C=CCn1cc2c(c1)OCCO2

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 1/20 0.32
ICAM1 P05362 1/20 0.32
ITGAL P20701 1/20 0.32
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL759276 0.75
SCHEMBL759275 0.65 PRCP (0.33)
SCHEMBL725361 0.65 GABRA1 (0.34) CYP3A4
SCHEMBL5960602 0.64 CYP3A4 (0.37) CYP3A4
SCHEMBL182699 0.63 CYP2D6 (0.51) ITGB2ICAM1ITGALCYP3A4
SCHEMBL182227 0.63 ITGB2 (0.43) ITGB2ICAM1ITGAL
SCHEMBL17626547 0.61 NPC1 (0.42)
SCHEMBL17646200 0.61 NPC1 (0.42)
SCHEMBL17646207 0.61 NPC1 (0.42)
Allylamine SCHEMBL27612901 0.61 ITGB2 (0.61) ITGB2ICAM1ITGALCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979916-B1 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS UNIV FLORIDA (US) 2012-03-21 EP claimed
US-7807758-B2 Chemical defunctionalization of polymeric alkylenedioxyheterocyclics UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2010-10-05 US claimed
US-20090221763-A1 Chemical Defunctionalization of Polymeric Alkylenedioxyheterocyclics UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2009-09-03 US claimed
EP-1979916-A2 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS University of Florida Research Foundation, Incorporated (US) 2008-10-15 EP claimed
WO-2007087587-A2 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2007-08-02 WO claimed
EP-2402955-B1 Chemical defunctionalization of polymeric alkylenedioxyheterocyclics - the monomers UNIV FLORIDA (US) 2013-07-03 EP disclosed
US-7807758-B2 Chemical defunctionalization of polymeric alkylenedioxyheterocyclics UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2010-10-05 US disclosed
US-20090221763-A1 Chemical Defunctionalization of Polymeric Alkylenedioxyheterocyclics UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2009-09-03 US disclosed
EP-1979916-A2 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS University of Florida Research Foundation, Incorporated (US) 2008-10-15 EP disclosed
WO-2007087587-A2 CHEMICAL DEFUNCTIONALIZATION OF POLYMERIC ALKYLENEDIOXYHETEROCYCLICS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221763-A1 Chemical Defunctionalization of Polymeric Alkylenedioxyheterocyclics DDT, STAT3, PTPN22 ITGB2 2691/4885ICAM1 4479/4885ITGAL 3030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.